Live Breaking News & Updates on Prnewswire Moberg Pharma

Stay updated with breaking news from Prnewswire moberg pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

MOB-015 is launched in Sweden under the brand name Terclara- pharmacies report major demand for the new medication

MOB-015 is launched in Sweden under the brand name Terclara- pharmacies report major demand for the new medication
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Hans Svartholm , Anna Ljung , Prnewswire Moberg Pharma , Moberg Pharma , Allderma Pharmaceuticals , Chief Medical Officer , Small Cap , Nasdaq Stockholm , Consumer Healthcare ,

Moberg Pharma: MOB-015 is launched in Sweden under the brand name Terclara- pharmacies report major demand for the new medication

Moberg Pharma: MOB-015 is launched in Sweden under the brand name Terclara- pharmacies report major demand for the new medication
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Anna Ljung , Prnewswire Moberg Pharma , Stefan Klotter , Hans Svartholm , Moberg Pharma , Allderma Pharmaceuticals , Chief Medical Officer , Small Cap , Nasdaq Stockholm , Consumer Healthcare , Die Performance Strategie , Assets Sie ,

Moberg Pharma has completed enrollment to the Phase 3 study for MOB-015 in North America

Moberg Pharma has completed enrollment to the Phase 3 study for MOB-015 in North America
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Prnewswire Moberg Pharma , Anna Ljung , Moberg Pharma , North American , Chief Medical Officer , Small Cap , Nasdaq Stockholm ,

MOB-015 is recommended for approval in EU: Moberg Pharma

/PRNewswire/ Moberg Pharma AB (OMX: MOB) hereby announces that the Decentralized Procedure has ended with a positive outcome and that MOB-015 is recommended. ....

United States , Czech Republic , Anna Ljung , Moberg Pharma , Prnewswire Moberg Pharma , Karen Hackney , European Union , Bayer Consumer Health Head , Neither The Company , Decentralized Procedure , North American , Small Cap , Nasdaq Stockholm ,

European marketing authorization application for MOB-015 submitted

/PRNewswire/ Moberg Pharma AB (publ) have submitted its marketing authorization application for MOB-015 (nail fungus treatment). The company has submitted. ....

Anna Ljung , Prnewswire Moberg Pharma , Moberg Pharma , Swedish Medical Products Agency , Marketing Authorization Application , Health Care Amp Hospitals , Pharmaceuticals , Medical Pharmaceuticals ,